Preliminary results of a accelerated dose escalation phase I trial with a novel anthracycline derivative (RTA-744) in patients with primary brain tumors

被引：0
|
作者：
Conrad, C. A.
Madden, T.
Meyer, C.
Preibe, W.
Baud, C.
Fokt, I.
Gilbert, M.
Groves, M.
Levin, V.
Yung, W. K. A.
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Reata Pharmaceut Inc, Dallas, TX USA
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70135-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
129
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [31] A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors
    Chu, Quincy S.
    Sangha, Randeep
    Hotte, Sebastien J.
    Sergenson, Gwen
    Schnell, David
    Chand, Vikram K.
    Hirte, Hal W.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) : 1226 - 1235
  • [32] A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors
    Quincy S. Chu
    Randeep Sangha
    Sebastien J. Hotte
    Gwen Sergenson
    David Schnell
    Vikram K. Chand
    Hal W. Hirte
    Investigational New Drugs, 2014, 32 : 1226 - 1235
  • [33] Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
    Melichar, B.
    Casado, E.
    Bridgewater, J.
    Bennouna, J.
    Campone, M.
    Vitek, P.
    Delord, J-P
    Cerman, J., Jr.
    Salazar, R.
    Dvorak, J.
    Sguotti, C.
    Urban, P.
    Viraswami-Appanna, K.
    Tan, E.
    Tabernero, J.
    BRITISH JOURNAL OF CANCER, 2011, 105 (11) : 1646 - 1653
  • [34] Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
    B Melichar
    E Casado
    J Bridgewater
    J Bennouna
    M Campone
    P Vitek
    J-P Delord
    J Cerman
    R Salazar
    J Dvorak
    C Sguotti
    P Urban
    K Viraswami-Appanna
    E Tan
    J Tabernero
    British Journal of Cancer, 2011, 105 : 1646 - 1653
  • [35] Phase I dose-escalation trial evaluating the safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors
    Awada, A.
    Gil, T.
    Whenham, N.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Loembe, B.
    Piccart, M.
    Hendlisz, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 39 - 39
  • [36] A phase I intermittent dose-escalation trial of ZD1839 (Iressa™) in Japanese patients with solid tumors.
    Uejima, H
    Nakagawa, K
    Fukuoka, M
    Tamura, T
    Kudoh, S
    Yoshimura, N
    Negoro, S
    Takeda, K
    Kelly, H
    ANNALS OF ONCOLOGY, 2000, 11 : 110 - 111
  • [37] A phase I/II dose escalation and expansion trial to evaluate safety and preliminary efficacy of BNT141 in patients with claudin-18.2-positive solid tumors
    Papadopoulos, Kyriakos P.
    Tehfe, Mustapha
    Razak, Albiruni Ryan Abdul
    Pant, Shubham
    Chung, Vincent
    Rasco, Drew W.
    Jamal, Rahima
    Willis, Jason
    Antras, Jesus Fuentes
    Brettschneider, Kerstin
    Zamorski, Alexandra
    Ahr-Mahmud, Hayat B. Spacing Diaeresis
    Koseoglu, Secil
    Chang, Philip K.
    Lindemann, Claudia
    Schlitter, Anna Melissa
    Magenheim, Rita
    De Mattos-Arruda, Leticia
    Tureci, Ozlem
    Sahin, Ugur
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Results of a phase 1 dose escalation clinical trial of NXP800, a novel GCN2 activator, in patients with advanced or metastatic solid tumors
    Banerji, Udai
    Pacey, Simon
    Finkelstein, Karen
    Rodney, Simon
    DosReis, Ana Filipa Palma
    Codaccipisanelli, Giovanni
    Sloan, Mark
    Raynaud, Florence I.
    Ruddle, Ruth
    Swales, Karen
    Tall, Matthew
    Shemesh, Shay
    Marsolini, Diane
    Sardone, Megan
    Hay, Justin
    Bliss, Robin
    Poradosu, Enrique
    Workman, Paul
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [39] Final results of a phase I dose escalation study of the safety and pharmacokinetics of foretinib administered orally daily to patients with solid tumors
    LoRusso, Patricia
    Eder, Joseph Paul
    Sherman, Laurie
    McCallum, Stewart
    Liu, Yuan
    Bottaro, Donald
    Cecchi, Fabiola
    Rabe, Daniel
    Miles, Dale
    Shapiro, Geoffrey
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [40] TQB2450 in patients with advanced malignant tumors: results from a phase I dose-escalation and expansion study
    Xue, Junli
    Xue, Liqiong
    Tang, Wenbo
    Ge, Xiaoxiao
    Zhao, Wei
    Li, Qun
    Peng, Wei
    Dai, Congqi
    Guo, Ye
    Li, Jin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
12345